Validation of COMPAT-SF Spanish Translation
ConditionChronic Pancreatitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMethodist Health System
About this trial
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Eligibility criteria
Qualifiers
18 years or older in age
Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
Able to read and understand the study information in Spanish
Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
Disqualifiers
Subjects who do not meet the criteria in section 4.1
Trial design
Treatments tested in this trial
- Questionnaires
Treatment groups
No treatment groups listed
Sponsors and collaborators
Methodist Health System
Lead sponsor
Aalborg University Hospital
Collaborator
Source ClinicalTrials.gov